The patient was injected with bellafill dermal filler off-label under the eyes about 3 years ago.
On (b)(6) 2019, the patient reported to suneva yellow discoloration under the eyes which had first appeared in (b)(6) 2018.
On (b)(6) 2019, after discussion with the injector, the discoloration was determined to be xanthelasma.
While xanthelasma is not harmful, it does require treatment to resolve.
The bellafill lot numbers used in the patient's procedure are unknown at this time and bellafill use has not been confirmed.
Suneva will continue to attempt to obtain the lot numbers from the account.
The patient denies any medical conditions or medications.
Injections under the eyes is off-label for bellafill.
Dr.
(b)(6) is aware of bellafill indications for use.
Bellafill dermal filler is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.
The exact age of the patient is unknown, however she is over 21.
Bellafill syringes are single use devices and are typically discarded after use.
Per the bellafill ifu: "the syringe and any unused material should be discarded after a single treatment visit.
".
|